National and Kapodistrian University of Athens
Η συμβολή της διουρηθρικής θερμοθεραπείας μικροκυμάτων με τη συσκευή prostalund compact στην αντιμετώπιση της αποφρακτικής καλοήθους υπερπλασίας του προστάτου
Abstract
dc:descriptionThe aim of this study was to evaluate the effectiveness and to investigatethe complication rates of Transurethral Microwave Thermotherapy (TUMT)with the ProstaLund Compact Device in the treatment of obstructive benignprostatic hyperplasia (BPH).From March 2000 to November 2002 we treated 38 patients using the newProstaLund Compact device, 19 of whom had an indwelling catheter. Theage was 72.6 ± 8.2 years ( 55-90 ). The prostatic mass was 63.5 ± 30 ml.The treatment investigation tests included TRUS, urodynamics andcystoscopy for all the patients, and flow rate with urine residue, IPSS andQOL for those without catheter. A réévaluation with a new flow rate, IPSSand QOL was performed after 3 months. At 6 and 12 months a urodynamicinvestigation was repeated with cystoscopy and TRUS as well.The treatment duration was 43.1 ± 17.1 min ( 12-70 ). The maximalintraprostatic temperature was 58.7 ± 7.2 °C ( 44.8-70.4 ). The calculateddestructed prostatic tissue was 18.4 ± 14.3 gr ( 0-54 ).In the group of the 19 patients without catheter the IPSS improvement at 3months was 55.3% [ 3 mo vs. base, p< 0.001 ], at 6 months 58.6% [ 6 movs. base, p< 0.001] and at 12 months 69.7% [ 12 mo vs. base, p< 0.001 ].The 12 month IPSS response rate ( IPSS< 7 or >50% improvement ) was73.7%. The maximum flow rate ( Qmax ) improved by 115% [ 3 mo vs.base, p< 0.001 ] , 159.7% [ 6 mo vs. base, p< 0.001] and 151.4% [ 12 movs. base, p< 0.001 ] respectively with a 12 month Qmax response rate( Qmax> 15ml/sec or >50% improvement ) of 84.2%. The urine residue( RU ) decreased by 66% [3 mo vs. base, p< 0.01 ], 77.5% [ 6 mo vs. base,p< 0.001] and 69.4% [ 12 mo vs. base, p< 0.01 ] respectively with a 12month RU response rate ( RU < 50 ml or >50% decrease ) of 73.7%.Significant drop of the median PdetQmax was seen both at 6 month and 12month values versus baseline [ base: 87.5 ± 15 cmH20; 6mo: 48.5 ± 18.3cmH20; 12 mo: 48.4± 16.4 cmH20 , p< 0.001 in both comparisons ]. TheQOL 12 month response rate ( QOL< 2 ) was 94.7%.Of the 19 patients with catheter 1 died of an unrelated to the treatmentreason and was excluded from the study and 2 were treatment failures ( could not urinate after the treatment and had to be operated ). Data for 14patients are available in the 12 month followup. The IPSS was at 3 months9.5 ± 6. At 6 months it improved by 34.2% [ 6 mo vs. 3 mo, p< 0.05 ] and at12 months by 46.3% [ 12 mo vs. 3 mo, p< 0.05 ]. The 12 month IPSSresponse rate ( IPSS< 7 ) was 75%. The Qmax was at 3 months 13.2 ± 6.4ml/sec. At 6 months it increased by 2.3% [ 6 mo vs. 3 mo, NS ] and at 12months it decreased by 7.8% [ 12 mo vs. 3 mo, NS ]. The Qmax 12 monthresponse rate ( Qmax > 15ml/sec ) was 25%. The urine residue was at 3months 43.4 ± 43.2 ml. At 6 months it increased by 38.8% [ 6 mo vs. 3 mo,p< 0.05 ] and at 12 months by 51.15% [ 12 mo vs. 3 mo, p< 0.05 ], with a 12month response rate (RU< 150ml) of 87.5%. The PdetQmax was at 6months 74.1 ± 12.6 cmH20 and at 12 months 60.2 ± 13.9 cmH20 [ 12 movs. 6 mo, NS, strong trend, p=0.07 ). The 12 month QOL response rate( QOL<2 ) was 75%.Post-treatment complications included UTIs in 9% of the patients, irritativesymptoms in 57.5% with a median duration of 11 weeks, and slighthematuria in 45.4% with a median duration of 5 weeks after the catheterremoval. Rejection of tissue fragments occurred in 66.6% of the patientswith a median duration of 7 days after treatment, while anejaculationoccurred in 30% of the sexually active patients and bladder stone formationin 15% of the patients in the annual follow up.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2003
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Ferakis, Nikolaos
- Φεράκης, Νικόλαος
Subjects
dc:subject × 16- Καλοήθης υπερπλασία προστάτη
- Αποφρακτική ΚΥΠ
- Επεμβατική θεραπεία
- Ελάχιστα επεμβατική θεραπεία
- Διουρηθρική θερμοθεραπεία με μικροκύματα
- Παλίνδρομη θεραπεία Prostalund
- Benign prostatic hyperplasia
- Obstructive BPH
- Interventional therapy
- Minimally invasive treatment
- Transurethral microwave thermotherapy
- Prostalynd feedback treatment
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23213